Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer
Authors
Keywords
-
Journal
Therapeutic Advances in Gastroenterology
Volume 5, Issue 5, Pages 319-337
Publisher
SAGE Publications
Online
2012-06-09
DOI
10.1177/1756283x12448456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations
- (2015) Katsuhiko Nosho et al. NEOPLASIA
- Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
- (2012) M.-H. Tan et al. CLINICAL CANCER RESEARCH
- Intestinal epithelial-specific PTEN inactivation results in tumor formation
- (2011) Do-Sun Byun et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- PI-3-Kinase Inhibitors in Colorectal Cancer
- (2011) N. T. Ihle et al. CURRENT CANCER DRUG TARGETS
- Adjuvant treatment of colon cancer: what is next?
- (2011) Katherine Van Loon et al. CURRENT OPINION IN ONCOLOGY
- Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP): A New Player in Cell Signaling
- (2011) Noel A. Warfel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers
- (2011) Hiromichi Ebi et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer
- (2011) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer
- (2011) Jatin Roper et al. PLoS One
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers
- (2010) Yoshifumi Baba et al. CANCER
- PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling
- (2010) E. Halilovic et al. CANCER RESEARCH
- The next thing in prognostic molecular markers: microRNA signatures of cancer
- (2010) W. M. Grady et al. GUT
- Colorectal cancer molecular biology moves into clinical practice
- (2010) C. C. Pritchard et al. GUT
- mTOR-Dependent Regulation of PHLPP Expression Controls the Rapamycin Sensitivity in Cancer Cells
- (2010) Jianyu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
- (2010) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL INVESTIGATION
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review
- (2010) F. U. Chowdhury et al. POSTGRADUATE MEDICAL JOURNAL
- Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment
- (2010) K. E. Hung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvant Therapy for Colon Cancer
- (2010) Leonard B. Saltz Surgical Oncology Clinics of North America
- Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
- (2009) J. Tol et al. ANNALS OF ONCOLOGY
- Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
- (2009) S. J. Cohen et al. ANNALS OF ONCOLOGY
- Evolving Treatment of Advanced Colon Cancer
- (2009) Neil H. Segal et al. Annual Review of Medicine
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
- (2009) S. Wee et al. CANCER RESEARCH
- PIKKing on PKB: regulation of PKB activity by phosphorylation
- (2009) Lana Bozulic et al. CURRENT OPINION IN CELL BIOLOGY
- Epithelial phosphatase and tensin homolog regulates intestinal architecture and secretory cell commitment and acts as a modifier gene in neoplasia
- (2009) Marie-Josée Langlois et al. FASEB JOURNAL
- Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium
- (2009) Daekee Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Induction of Akt Activity by Chemotherapy Confers Acquired Resistance
- (2009) Wei-Chien Huang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- -TrCP-Mediated Ubiquitination and Degradation of PHLPP1 Are Negatively Regulated by Akt
- (2009) X. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer
- (2009) M. L. Sos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal Cancer
- (2008) Lisa Simi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
- (2008) Sérgia Velho et al. BMC CANCER
- Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
- (2008) N. Rhodes et al. CANCER RESEARCH
- Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance
- (2008) N. T. Ihle et al. CANCER RESEARCH
- Tenets of PTEN Tumor Suppression
- (2008) Leonardo Salmena et al. CELL
- Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
- (2008) J. A. Engelman et al. CLINICAL CANCER RESEARCH
- Acquired resistance to tyrosine kinase inhibitors during cancer therapy
- (2008) Jeffrey A Engelman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Systemic Treatment of Colorectal Cancer
- (2008) Brian M. Wolpin et al. GASTROENTEROLOGY
- Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
- (2008) Ludovic Barault et al. INTERNATIONAL JOURNAL OF CANCER
- Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation
- (2008) Victoria Marsh et al. NATURE GENETICS
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PTEN–PI3K pathway: of feedbacks and cross-talks
- (2008) A Carracedo et al. ONCOGENE
- Class I PI3K in oncogenic cellular transformation
- (2008) L Zhao et al. ONCOGENE
- Drug discovery approaches targeting the PI3K/Akt pathway in cancer
- (2008) C Garcia-Echeverria et al. ONCOGENE
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
- Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer
- (2008) Yanan Yang et al. PLoS One
- Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc 716 mice
- (2008) T. Fujishita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PTEN-deficient cancers depend on PIK3CB
- (2008) S. Wee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of insulin-like growth factor-1R system in colorectal carcinogenesis
- (2007) Erin A. Donovan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started